NASDAQ
C4 Therapeutics, Inc. (CCCC) has a free cash flow growth of -35.44% as of Friday, May 29, 2026. This represents a 5.99% increase compared to its 12-month average of -37.70%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.